COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity K Lundstrom, A Hromić-Jahjefendić, E Bilajac, AAA Aljabali, K Baralić, ... Cellular Signalling 101, 110495, 2023 | 19 | 2023 |
Metformin and thymoquinone synergistically inhibit proliferation of imatinib-resistant human leukemic cells U Glamoclija, L Mahmutovic, E Bilajac, V Soljic, K Vukojevic, M Suljagic Frontiers in pharmacology 13, 867133, 2022 | 11 | 2022 |
COVID-19 signalome: Potential therapeutic interventions K Lundstrom, A Hromić-Jahjefendić, E Bilajac, AAA Aljabali, K Baralić, ... Cellular signalling 103, 110559, 2023 | 8 | 2023 |
Meet the insidious players: Review of viral infections in head and neck cancer etiology with an update on clinical trials L Mahmutović, E Bilajac, A Hromić-Jahjefendić Microorganisms 9 (5), 1001, 2021 | 8 | 2021 |
Curcumin decreases viability and inhibits proliferation of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cell lines E Bilajac, L Mahmutović, U Glamočlija, A Osmanović, ... Metabolites 13 (1), 58, 2022 | 6 | 2022 |
Viral agents as potential drivers of diffuse large B-Cell lymphoma tumorigenesis E Bilajac, L Mahmutović, K Lundstrom, U Glamočlija, J Šutković, A Sezer, ... Viruses 14 (10), 2105, 2022 | 4 | 2022 |
HPLC method for the determination of thymoquinone in growth cell medium M Dedić, E Omeragić, B Imamović, E Bilajac, L Mahmutović, U Glamočlija, ... Technology and Health Care, 1-14, 2024 | | 2024 |
SYNTHESIS, IN SILICO STUDY AND ANTITUMOR ACTIVITY OF COUMARIN COMPOUNDS IN LYMPHOMA CELLS E Bilajac, A OSMANOVIĆ, UNA GLAMOČLIJA, E VELJOVIĆ, ... Farmacia 71 (6), 1263-1273, 2023 | | 2023 |
Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells E Bilajac, U Glamočlija, A Osmanović, L Mahmutović, A Sezer, S Roca, ... Croatica chemica acta 96 (1), 59-68, 2023 | | 2023 |